Your browser doesn't support javascript.
loading
Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial.
Nam, Hyo Suk; Kim, Young Dae; Heo, JoonNyung; Lee, Hyungwoo; Jung, Jae Wook; Choi, Jin Kyo; Lee, Il Hyung; Lim, In Hwan; Hong, Soon-Ho; Baik, Minyoul; Kim, Byung Moon; Kim, Dong Joon; Shin, Na-Young; Cho, Bang-Hoon; Ahn, Seong Hwan; Park, Hyungjong; Sohn, Sung-Il; Hong, Jeong-Ho; Song, Tae-Jin; Chang, Yoonkyung; Kim, Gyu Sik; Seo, Kwon-Duk; Lee, Kijeong; Chang, Jun Young; Seo, Jung Hwa; Lee, Sukyoon; Baek, Jang-Hyun; Cho, Han-Jin; Shin, Dong Hoon; Kim, Jinkwon; Yoo, Joonsang; Lee, Kyung-Yul; Jung, Yo Han; Hwang, Yang-Ha; Kim, Chi Kyung; Kim, Jae Guk; Lee, Chan Joo; Park, Sungha; Lee, Hye Sun; Kwon, Sun U; Bang, Oh Young; Anderson, Craig S; Heo, Ji Hoe.
Afiliación
  • Nam HS; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Kim YD; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Heo J; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Lee H; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Jung JW; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Choi JK; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Lee IH; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Lim IH; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Hong SH; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Baik M; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Kim BM; Department of Radiology, Yonsei University College of Medicine, Seoul, Korea.
  • Kim DJ; Department of Radiology, Yonsei University College of Medicine, Seoul, Korea.
  • Shin NY; Department of Radiology, Yonsei University College of Medicine, Seoul, Korea.
  • Cho BH; Department of Neurology, Korea University Anam Hospital and College of Medicine, Seoul, Korea.
  • Ahn SH; Department of Neurology, Chosun University School of Medicine, Gwangju, Korea.
  • Park H; Department of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea.
  • Sohn SI; Department of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea.
  • Hong JH; Department of Neurology, Brain Research Institute, Keimyung University School of Medicine, Daegu, Korea.
  • Song TJ; Department of Neurology, Seoul Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
  • Chang Y; Department of Neurology, Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
  • Kim GS; Department of Neurology, National Health Insurance Service, Ilsan Hospital, Goyang, Korea.
  • Seo KD; Department of Neurology, National Health Insurance Service, Ilsan Hospital, Goyang, Korea.
  • Lee K; Department of Neurology, National Health Insurance Service, Ilsan Hospital, Goyang, Korea.
  • Chang JY; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Seo JH; Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Lee S; Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Baek JH; Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Cho HJ; Department of Neurology, Pusan National University School of Medicine, Busan, Korea.
  • Shin DH; Department of Neurology, Gachon University Gil Medical Center, Incheon, Korea.
  • Kim J; Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
  • Yoo J; Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
  • Lee KY; Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Jung YH; Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Hwang YH; Department of Neurology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
  • Kim CK; Department of Neurology, Korea University Guro Hospital and College of Medicine, Seoul, Korea.
  • Kim JG; Department of Neurology, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea.
  • Lee CJ; Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Park S; Integrative Research Center for Cerebrovascular and Cardiovascular Diseases, Yonsei University College of Medicine, Division of Cardiology, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
  • Lee HS; Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea.
  • Kwon SU; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Bang OY; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Anderson CS; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Heo JH; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
JAMA ; 330(9): 832-842, 2023 09 05.
Article en En | MEDLINE | ID: mdl-37668619
ABSTRACT
Importance Optimal blood pressure (BP) control after successful reperfusion with endovascular thrombectomy (EVT) for patients with acute ischemic stroke is unclear.

Objective:

To determine whether intensive BP management during the first 24 hours after successful reperfusion leads to better clinical outcomes than conventional BP management in patients who underwent EVT. Design, Setting, and

Participants:

Multicenter, randomized, open-label trial with a blinded end-point evaluation, conducted across 19 stroke centers in South Korea from June 2020 to November 2022 (final follow-up, March 8, 2023). It included 306 patients with large vessel occlusion acute ischemic stroke treated with EVT and with a modified Thrombolysis in Cerebral Infarction score of 2b or greater (partial or complete reperfusion).

Interventions:

Participants were randomly assigned to receive intensive BP management (systolic BP target <140 mm Hg; n = 155) or conventional management (systolic BP target 140-180 mm Hg; n = 150) for 24 hours after enrollment. Main Outcomes and

Measures:

The primary outcome was functional independence at 3 months (modified Rankin Scale score of 0-2). The primary safety outcomes were symptomatic intracerebral hemorrhage within 36 hours and death related to the index stroke within 3 months.

Results:

The trial was terminated early based on the recommendation of the data and safety monitoring board, which noted safety concerns. Among 306 randomized patients, 305 were confirmed eligible and 302 (99.0%) completed the trial (mean age, 73.0 years; 122 women [40.4%]). The intensive management group had a lower proportion achieving functional independence (39.4%) than the conventional management group (54.4%), with a significant risk difference (-15.1% [95% CI, -26.2% to -3.9%]) and adjusted odds ratio (0.56 [95% CI, 0.33-0.96]; P = .03). Rates of symptomatic intracerebral hemorrhage were 9.0% in the intensive group and 8.1% in the conventional group (risk difference, 1.0% [95% CI, -5.3% to 7.3%]; adjusted odds ratio, 1.10 [95% CI, 0.48-2.53]; P = .82). Death related to the index stroke within 3 months occurred in 7.7% of the intensive group and 5.4% of the conventional group (risk difference, 2.3% [95% CI, -3.3% to 7.9%]; adjusted odds ratio, 1.73 [95% CI, 0.61-4.92]; P = .31). Conclusions and Relevance Among patients who achieved successful reperfusion with EVT for acute ischemic stroke with large vessel occlusion, intensive BP management for 24 hours led to a lower likelihood of functional independence at 3 months compared with conventional BP management. These results suggest that intensive BP management should be avoided after successful EVT in acute ischemic stroke. Trial Registration ClinicalTrials.gov Identifier NCT04205305.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Presión Sanguínea / Trombectomía / Accidente Cerebrovascular Isquémico / Estado Funcional / Antihipertensivos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: JAMA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Presión Sanguínea / Trombectomía / Accidente Cerebrovascular Isquémico / Estado Funcional / Antihipertensivos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: JAMA Año: 2023 Tipo del documento: Article